Dyne Therapeutics Inc (DYN) — Capital Reinvestment Ratio
Latest as of December 2017:
2.67x
Dyne Therapeutics Inc (DYN) has a Capital Reinvestment Ratio of 2.67x as of December 2017, meaning it reinvests 3% of its operating cash flow ($84.00 Million) in capital expenditures ($224.00 Million). See DYN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.67x
Capex / Operating Cash Flow
Operating Cash Flow
$84.00 Million
USD
Capital Expenditures
$224.00 Million
USD
Data as of
Dec 2017
Most recent filing
Dyne Therapeutics Inc Capital Reinvestment Ratio (2010–2017)
This chart tracks Dyne Therapeutics Inc's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Dyne Therapeutics Inc (2010–2017)
Year-by-year Capital Reinvestment Ratio for Dyne Therapeutics Inc from 2010 to 2017. For live market cap and broader valuation context, see Dyne Therapeutics Inc (DYN) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.38x | $585.00 Million | $224.00 Million | ▼ -20.6% |
| 2016 | 0.48x | $676.00 Million | $326.00 Million | ▼ -83.5% |
| 2015 | 2.93x | $94.00 Million | $275.00 Million | ▲ +422.4% |
| 2013 | 0.56x | $175.00 Million | $98.00 Million | ▼ -28.9% |
| 2010 | 0.79x | $423.00 Million | $333.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow